Fundraising FoxBlue Heron Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
RejuvenAir, developed by CSA Medical, is a bronchoscopic cryosurgical device that sprays metered doses of liquid nitrogen to destroy damaged airway cells and treat the underlying cause of COPD with Chronic Bronchitis.
HealthtechMedical DevicesLutherville, US
Ellen Sheets(Executive Officer, Director)inIan J. Vawter(Executive Officer)Steven Schaefer(Executive Officer)inWilliam Floyd(Executive Officer, Director)inWendelin ManersinVincent Owens(Director)
Co-investorsAscension VenturesFirst AnalysisNew Markets Venture PartnersSV Health InvestorsTVM CapitalTVM Capital Life Science
Redi Health builds patient access and affordability programs that connect pharmaceutical manufacturers to patients through targeted approaches designed to increase medication adoption and sustained use.
Digital HealthHealthtechSaaS
Luke Buchanan(Co-Founder & CEO)inJaimin Gandhi(Co-Founder & CTO)inKyle Grimslid(Co-Founder & CSO)inNate Rehm(Co-Founder & CRO)in
Co-investorsMutual Capital PartnersPlug and Play VenturesRefinery VentureM25Rev1 Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.